Long-term use of proton pump inhibitors in patients who have ever had Helicobacter pylori infection more than doubles the risk of developing stomach cancer, new research suggests. The large population study published online in Gut found a 2.4 fold increased risk in patients who had been treated for H pylori, with dose and duration associated with even higher risk. Previous research ...
Expert: PPI link to stomach cancer has “important clinical implications
By Tessa Hoffman
2 Nov 2017